OTC Markets Group Inc
OTC:OTCM

Watchlist Manager
OTC Markets Group Inc Logo
OTC Markets Group Inc
OTC:OTCM
Watchlist
Price: 53.06 USD -1.9%
Market Cap: $637.8m

OTC Markets Group Inc
Investor Relations

OTC Markets Group, Inc. engages in the provision of trading, corporate, and market data services. The company is headquartered in New York City, New York. The company went IPO on 2009-09-16. Through its OTC Link Alternative Trading Systems (ATSs), the Company connects a diverse network of broker-dealers that provide liquidity and execution services. The company enables investors to trade through the broker of their choice and allow companies to improve the information for investors. The company has three business lines: OTC Link, Market Data Licensing and Corporate Services. Its OTC Link LLC operates three ATSs, OTC Link ATS, OTC Link ECN and OTC Link NQB, which provide trading services to a Financial Industry Regulatory Authority, Inc. (FINRA) member broker-dealer subscribers. Market Data Licensing provides investors, traders, institutions and regulators with a suite of enterprise and user market data licenses. Its Corporate Services operates OTCQX and OTCQB that offers disclosure and information services.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 13, 2025
AI Summary
Q3 2025

Strong Revenue Growth: Gross and net revenues both increased by 15% in Q3, marking the third consecutive quarter of double-digit growth across all business lines.

Segment Highlights: OTC Link revenue surged 23%, Market Data rose 15% (driven by price increases), and Corporate Services grew 12%, with particular strength from the new OTCID Basic Market.

Margin Expansion: Operating profit margin improved to 34.6% from 32.4% last year, and operating income rose 23%.

Earnings & Cash: Diluted EPS was $0.71, up 16%, while operating cash flow and free cash flow more than doubled to $13.3 million.

Dividend Declaration: A special dividend of $1.75 and a regular quarterly dividend of $0.18 per share, both payable in December, were announced.

Strategic Initiatives: Successful launch and rapid uptake of the OTCID Basic Market, and continued momentum in Overnight Trading following regulatory changes in South Korea.

Expense Management: Operating expenses increased 8%, mainly from higher compensation and consulting fees, but were outpaced by revenue growth.

Key Financials
Gross Revenue
$31.6 million
Operating Expenses
$17.9 million
Operating Profit Margin
34.6%
Diluted EPS
$0.71
Adjusted EBITDA
$12.8 million
Adjusted Diluted EPS
$1.06
Operating Cash Flow
$13.3 million
Free Cash Flow
$13.3 million
Dividends Returned to Investors
$2.2 million
Special Dividend
$1.75 per share
Quarterly Dividend
$0.18 per share
OTC Link ECN Subscribers
114
OTC Link ATS Subscribers
77
Unique ATS Subscribers
138
OTCQX Companies (End of Q3)
553
OTCQB Companies (End of Q3)
1,097
OTCID Basic Market Companies (End of Q3)
1,077
Combined OTCID and Pink Limited DNS Subscribers
1,511
Earnings Call Recording
Other Earnings Calls

Management

Mr. Robert Cromwell Coulson
President, CEO & Director
No Bio Available
Ms. Antonia Georgieva
Chief Financial Officer
No Bio Available
Mr. Bruce Ostrover
Chief Technology Officer
No Bio Available
Ms. Lisabeth Heese
Executive Vice President of Issuer & Information Services
No Bio Available
Mr. Daniel Zinn J.D.
Chief of Staff, General Counsel & Corporate Secretary
No Bio Available
Mr. Jason L. Paltrowitz
Executive Vice President of Corporate Services
No Bio Available
Mr. Matthew Fuchs
Executive Vice President of Market Data Licensing
No Bio Available
Mr. Michael Richard Modeski
President of OTC Link LLC
No Bio Available
Ms. Kristie Harkins
Chief Marketing Officer
No Bio Available
Mr. Bob Power
Senior Vice President of Corporate Services
No Bio Available

Contacts

Address
NEW YORK
New York City
300 Vesey Street, 12th Floor
Contacts
+12128964400.0
www.otcmarkets.com